Member Info for Womo

It went crazy in last ten miniutes and some very chunky buys.

Getting hammered.

Moving up nicely.

I think it was 10 weeks from end of stage 2.

hey ho but moving in right direction.

I agree it makes no difference in the grand scheme. Just giving a balanced view and not just reporting large buys.

its a sell.

just gone through too.

1m+ buys coming in.

Only a matter of time - The news could be amazing if PH3 goes well and we look for JV partner.

https://www.worldpharmatoday.com/news/n4-pharma-exploring-how-nuvec-can-be-used-to-help-fight-covid-19/

Sorry if posted before - but his does give a clear signal of what may come soon:-
https://mcusercontent.com/d9ebd7c1aa0f3dbc5fab42eca/files/8f6b6345-9d05-4dc5-91fd-45b284405dec/N4Pharma_13_8_2020_FINAL_BG.pdf

Norrinrad - as below
3. subject to positive results being achieved at stage 2, undertaking an initial pre in vivo study to demonstrate expression of the spike protein in target cells in a murine target. This stage would be expected to take a further ten weeks, commencing in mid-July.

Once the stage 3 results have been reviewed, the Company will then determine whether to do a further in vivo study to demonstrate the capability of Nuvec® to generate Covid-19 specific antibodies. In light of the current global urgency around treatments for Covid-19, the Company would also seek to collaborate, where it can, with appropriate partners to accelerate further studies at this juncture.

This is exciting - a delivery system for vaccines. staggering potential.

"We are delighted to have achieved in vitro transfection of HEK cells with Nuvec® loaded with coronavirus plasmid. We now move straight to the third stage of our Covid-19 project with our pre in vivo study at Evotec. The global pandemic continues to dominate all of our lives and we are extremely excited to be moving onto the next stage of our Covid-19 project, the successful outcome of which will determine our next work streams in this area and how we might collaborate with appropriate partners interested in any advantage our Nuvec® delivery system may provide. We look forward to providing updates on this project and our other work streams in due course."

Aug 10, 2020 5,848,448
Aug 7, 2020 706,102
Aug 6, 2020 440,860
Aug 5, 2020 1,120,933
Aug 4, 2020 739,104
Aug 3, 2020 441,715

and hopefully good news to come soon regarding Evotec results.
Of course any further news on the oral Nuvec Potential Oral Applications and we can kiss this level of SP goodbye. Quote - "However, recent research on Nuvec® indicates that its unique spiky structure could give it a significant competitive advantage as a potential delivery system for use in oral vaccines."

Yes and over 60m shares held by major shareholders and directors.

with only 152m shares.

Well 10p was inevitable wasn't it?
Lenovo partnership, Intrinsic investment at 10p.
This was the easiest investment choice I have ever had it was just a matter of when.
Good luck to all and I think this is just the start.